Watch our latest webinar: Who can you trust? A pharma leader’s guide to vetting AI for insights
View Now
Product manager
Our thinking
Insights, strategy, and perspectives from the Day One team
Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster sense-making, broader exploration, and decisions made with greater confidence when time is short.
Day One founders Abigail Stuart and Hannah Mann share their perspective on how female leadership can bring different thinking to healthcare, strengthen culture and improve decision-making across the industry.
Our AI in Pharma State of Play research shows insights professionals moving from producing the work to directing teams of AI agents.
Data quality now holds pharma insights back more than access to AI and the fix starts with how we structure research today.
As AI tools become universal, competitive advantage will come from rich, fresh human insight that grounds and challenges synthetic customers.
Abigail Stuart reflects on how her views on AI have changed, and why she now sees primary research as one of pharma's most valuable assets.
AI personas can help pharma teams sharpen messages and concepts before committing budget to research, if the intelligence behind them is right.
Intelligence-native organisations never sleep, so insight agencies must evolve into always-on partners embedded in their clients' decisions.
AI only matters in market research when it improves decisions, shapes investment, and increases the odds of market success.
Most insight leaders can now see the strategic potential of AI. They understand where it could help them with faster sense-making, broader exploration, and decisions made with greater confidence when time is short.
